Corvus Pharmaceuticals CRVS Other operating expenses
Other operating expenses at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's other operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's other operating expenses?
- Corvus Pharmaceuticals (CRVS) reported other operating expenses of $14.88M in Q1 2026.
- How has Corvus Pharmaceuticals's other operating expenses changed year-over-year?
- Corvus Pharmaceuticals's other operating expenses increased by 49.9% year-over-year, from $9.92M to $14.88M.
- What is the long-term trend for Corvus Pharmaceuticals's other operating expenses?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's other operating expenses has grown at a 2.7% compound annual growth rate (CAGR), from $38.63M to $42.97M.
- What does other operating expenses mean?
- Residual operating expenses not classified into specific categories, serving as a catch-all for miscellaneous operating costs.